Body mass index and mortality in patients receiving Extracorporeal Membrane Oxygenation: an analysis of the Chinese extracorporeal life support registry
In a nationwide Chinese cohort of over 13,000 ECMO patients, this study reveals a nonlinear association between body mass index and in-hospital mortality, where overweight and obesity independently increase the risk of death compared to normal weight, suggesting BMI should be integrated into multidimensional risk stratification rather than used as an isolated selection criterion.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
When the heart or lungs fail so completely that the body cannot survive on its own, doctors sometimes turn to a machine called extracorporeal membrane oxygenation, or ECMO. This device acts as an external heart and lung, pumping blood out of the body, adding oxygen, removing carbon dioxide, and returning it to the patient. It is a last-resort lifeline for people with severe respiratory or circulatory failure. However, deciding who is strong enough to survive this intense treatment is difficult. One factor that has long puzzled doctors is body weight. For years, a theory known as the "obesity paradox" suggested that being overweight might actually help patients survive critical illnesses, perhaps because extra body fat provides a reserve of energy during a crisis. Yet, other data hinted that excess weight could make the procedure harder to perform and increase the risk of complications. Because body fat behaves differently in people of different ethnic backgrounds, and because most previous studies focused on Western populations, it remained unclear how body weight truly affects survival chances for patients in China receiving this life-saving support.
To settle this question, a team of researchers from across China conducted a massive review of medical records spanning more than a decade. They gathered data from over 13,000 adult patients who received ECMO treatment between 2014 and 2025. The study was unique because it used specific body weight guidelines tailored to the Chinese population, where the thresholds for being considered overweight or obese are lower than the international standards used in the West. The researchers divided the patients into four groups based on their body mass index, a calculation of weight relative to height: those who were underweight, those with a normal weight, those who were overweight, and those with obesity. They then tracked how many patients in each group survived their hospital stay and compared these outcomes while carefully accounting for other factors like age, heart disease, diabetes, and the severity of their illness before treatment began.
The results painted a clear picture that challenges the idea that extra weight offers protection. The study found that patients who were overweight or had obesity were significantly more likely to die in the hospital compared to those with a normal body weight. Specifically, the risk of death was about 15 percent higher for overweight patients and 26 percent higher for those with obesity. In contrast, patients who were underweight did not show a statistically significant increase in death rates compared to the normal-weight group, though their numbers were slightly higher. The researchers also discovered that the relationship between body weight and survival was not a straight line. Instead, it followed a curved pattern where the lowest chance of death occurred at a body mass index of approximately 21.5, which falls comfortably within the normal weight range. As body weight moved away from this point in either direction, the risk of death tended to rise, but the increase was most pronounced and consistent for those on the heavier side.
This pattern held true regardless of how the machine was used or the specific type of illness the patient had. Whether the ECMO was supporting the heart and lungs together or just the lungs, and whether the patient had high blood pressure, diabetes, or heart failure, the trend remained the same: higher body weight was linked to a higher risk of death. The study also looked at why patients died and found that the cause of death did not change based on body weight; organ failure was the leading cause of death for everyone, regardless of their size. This suggests that the extra risk for heavier patients is not due to a single specific complication, but rather a combination of factors. Heavier patients often entered treatment with a higher burden of heart and metabolic diseases, and the physical demands of the procedure, such as accessing blood vessels and positioning the patient, may be more difficult with excess body weight.
The researchers concluded that while body weight should not be used as a sole reason to deny someone ECMO treatment, it is a vital piece of information for understanding a patient's risk. The data suggests that being overweight or obese independently increases the odds of dying during hospitalization for these critical cases. This finding helps doctors move away from the hope that extra weight might be a shield against death and instead encourages a more careful, individualized approach to risk assessment. By recognizing that the body's response to this extreme support changes with weight, medical teams can better prepare for the challenges these patients face and tailor their care to improve the chances of survival. The study reinforces that in the high-stakes world of critical care, maintaining a body weight within the normal range appears to offer the most favorable outlook for recovery.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.